MEDIFAST INC 8-K

What Happened
Medifast, Inc. announced its financial results for the quarter ended March 31, 2026 via a press release issued on May 4, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K dated May 4, 2026. The filing notes the furnished information is not deemed "filed" under the Securities Exchange Act and is not incorporated by reference into other filings except by specific reference.

Key Details

• Date of filing/press release: May 4, 2026.
• Reporting period: Quarter ended March 31, 2026.
• Exhibit included: Press release furnished as Exhibit 99.1 (and Inline XBRL cover page 104.1).
• Signature: Form 8‑K signed by James P. Maloney, Chief Financial Officer.

Why It Matters
This 8‑K notifies investors that Medifast has released its Q1 2026 results; the 8‑K itself does not include the financial figures. Investors should review Exhibit 99.1 (the company’s press release) for revenue, earnings, and other performance metrics to assess near‑term operating results and any guidance or management commentary included in that release.